{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:53:54Z","timestamp":1783421634088,"version":"3.54.6"},"reference-count":39,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2024,2,22]]},"DOI":"10.18632\/oncotarget.28561","type":"journal-article","created":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:48:04Z","timestamp":1708606084000},"page":"134-141","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health"],"prefix":"10.18632","volume":"15","author":[{"given":"Elisabetta","family":"De Matteis","sequence":"first","affiliation":[{"name":"U.O.S.V.D. Oncological Screenings, \u201cVito Fazzi\u201d Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Tumolo","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tarantino","sequence":"additional","affiliation":[{"name":"U.O.C. Medical Genetics, \u201cVito Fazzi\u201d Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Ciccarese","sequence":"additional","affiliation":[{"name":"Strategic Regional Agency for Health and Social of Puglia, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Grassi","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bagordo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy-Pharmaceutical Sciences, University of Bari \u201cAldo Moro\u201d, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rita","family":"De Giorgio","sequence":"additional","affiliation":[{"name":"U.O.S.V.D. Oncological Screenings, \u201cVito Fazzi\u201d Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Department of Biological and Environmental Sciences and Technology, University of Salento, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Ronzino","sequence":"additional","affiliation":[{"name":"Oncology Unit, \u201cVito Fazzi\u201d Hospital, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2024,2,22]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors","volume":"1","author":"Salehiniya","year":"2019","journal-title":"Int J Womens Health"},{"key":"2","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"39","author":"Manchanda","year":"2021","journal-title":"Lancet"},{"key":"3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"7","author":"Bray","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"4","unstructured":"I numeri del cancro in Italia, 2022. AIOM-Registri Tumori Italiani-SIAPEC-PASSI-PASSI D\u2019ARGENTO-ONS-Fondazione AIOM."},{"key":"5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ygyno.2021.04.014","article-title":"Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21)","volume":"16","author":"Spagnoletti","year":"2021","journal-title":"Gynecol Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/cancers14020416","article-title":"The Evolution of Ovarian Carcinoma Subclassification","volume":"1","author":"Kang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"21","author":"Crum","year":"2007","journal-title":"J Pathol"},{"key":"8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/J.MPDHP.2021.09.004","article-title":"Ovarian borderline tumours and carcinomas: an update","volume":"2","author":"Gilks","year":"2021","journal-title":"Diagn Histopathol"},{"key":"9","doi-asserted-by":"publisher","first-page":"100629","DOI":"10.1016\/j.ctarc.2022.100629","article-title":"Epithelial ovarian cancer: Review article","volume":"3","author":"Sambasivan","year":"2022","journal-title":"Cancer Treat Res Commun"},{"key":"10","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.4103\/ijc.IJC_1394_20","article-title":"mutations: Implications of genetic testing in ovarian cancer","volume":"5","author":"Rauthan","year":"2022","journal-title":"Indian J Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","article-title":"Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer","volume":"31","author":"DiCarlo","year":"2018","journal-title":"JAMA"},{"key":"12","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1200\/JCO.2017.72.3502","article-title":"Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma","volume":"3","author":"Borges","year":"2017","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1200\/EDBK_238977","article-title":"The Role ofTesting in Hereditary Pancreatic and Prostate Cancer Families","volume":"3","author":"Pilarski","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"14","doi-asserted-by":"publisher","first-page":"19248","DOI":"10.1038\/s41598-020-76385-8","article-title":"Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes","volume":"1","author":"Giraud","year":"2020","journal-title":"Sci Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers","volume":"31","author":"Rookus","year":"2017","journal-title":"JAMA"},{"key":"16","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1038\/ejhg.2016.93","article-title":"The biological effects and clinical implications of BRCA mutations: where do we go from here?","volume":"2","author":"Stoppa-Lyonnet","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"17","doi-asserted-by":"publisher","first-page":"9873954","DOI":"10.1155\/2020\/9873954","article-title":"Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in: A Review of Secondary Prevention Guidelines","volume":"202","author":"Dekervel","year":"2020","journal-title":"J Oncol"},{"key":"18","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1136\/ijgc-2020-001556","article-title":"Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes","volume":"3","author":"Fagotti","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/genes12071050","article-title":"Differences in Ovarian and Other Cancers Risks by Population andMutation Location","volume":"1","author":"Enomoto","year":"2021","journal-title":"Genes (Basel)"},{"key":"20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations","volume":"3","author":"Chan","year":"2018","journal-title":"Hum Mutat"},{"key":"21","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/cancers12051158","article-title":"Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants inGenes","volume":"1","author":"Bazan","year":"2020","journal-title":"Cancers (Basel)"},{"key":"22","doi-asserted-by":"publisher","first-page":"22353","DOI":"10.18632\/oncotarget.24959","article-title":"BRCAmut and \u201cfounder effect\u201d: a prospective study in a single academic institution","volume":"9","author":"Cormio","year":"2018","journal-title":"Oncotarget"},{"key":"23","first-page":"1","article-title":"Italy: Health System Review","volume":"2","author":"Scarpetti","year":"2022","journal-title":"Health Syst Transit"},{"key":"24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13048-023-01094-5","article-title":"Clinical application of PARP inhibitors in ovarian cancer: from molecular mechanisms to the current status","volume":"1","author":"Wang","year":"2023","journal-title":"J Ovarian Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10549-010-1043-4","article-title":"Comparative effectiveness of screening and prevention strategies among BRCA1\/2-affected mutation carriers","volume":"12","author":"Neugut","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"12","author":"Moller","year":"2019","journal-title":"Br J Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/s41436-020-0751-3","article-title":"Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers","volume":"2","author":"Trainer","year":"2020","journal-title":"Genet Med"},{"key":"28","doi-asserted-by":"publisher","first-page":"e58182","DOI":"10.1371\/journal.pone.0058182","article-title":"Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases","volume":"8","author":"Papadimitriou","year":"2013","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3390\/genes11080925","article-title":"Prevalence and Spectrum ofGermline Variants in Central Italian High Risk or Familial Breast\/Ovarian Cancer Patients: A Monocentric Study","volume":"1","author":"Roila","year":"2020","journal-title":"Genes (Basel)"},{"key":"30","doi-asserted-by":"publisher","first-page":"682445","DOI":"10.3389\/fonc.2021.682445","article-title":"Prevalence and Spectrum of GermlineandVariants of Uncertain Significance in Breast\/Ovarian Cancer: Mysterious Signals From the Genome","volume":"1","author":"Pivetti","year":"2021","journal-title":"Front Oncol"},{"key":"31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13046-020-01554-6","article-title":"Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers","volume":"3","author":"Soddu","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejim.2016.03.010","article-title":"Mutation detection rates associated with specific selection criteria for BRCA1\/2 testing in 1854 high-risk families: A monocentric Italian study","volume":"3","author":"Manoukian","year":"2016","journal-title":"Eur J Intern Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.1515\/cclm-2020-0389","article-title":"A new founderhaplotype identified in the Puglia region is associated with a specific age-related cancer onset in three unrelated families","volume":"5","author":"Genuardi","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.3390\/cancers13184714","article-title":"Spectrum of Germline Pathogenic Variants in BRCA1\/2 Genes in the Apulian Southern Italy Population: Geographic Distribution and Evidence for Targeted Genetic Testing","volume":"1","author":"Tarantino","year":"2021","journal-title":"Cancers (Basel)"},{"key":"35","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3390\/cancers12051286","article-title":"Spectrum of GermlineandVariants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome","volume":"1","author":"Capoluongo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"36","doi-asserted-by":"publisher","first-page":"100459","DOI":"10.1016\/j.esmoop.2022.100459","article-title":"Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies","volume":"7","author":"Del Re","year":"2022","journal-title":"ESMO Open"},{"key":"37","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","article-title":"Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results","volume":"2","author":"Tavtigian","year":"2008","journal-title":"Hum Mutat"},{"key":"38","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","article-title":"ClinVar: public archive of relationships among sequence variation and human phenotype","volume":"4","author":"Maglott","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"39","unstructured":"ClinVar n.d. https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/ (accessed October 1, 2023)."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T12:49:19Z","timestamp":1708606159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,22]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2,22]]}},"alternative-id":["28561"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28561","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,22]]}}}